ipilimumab,nivolumab,
bms,delcath systems
['chopin']
$dcth positive initial results from chopin phase 1b trial, focus trial update and qol study presented at the 2022 asco annual meeting stock news alerts in bio
Over 500 members. DM us for our premium stock alerts.